GM

General Motors

$87.40

+1.96%
Oct 30, 2026
Bobby Quantitative Model
General Motors is a global automaker that designs, builds, and sells vehicles, parts, and accessories across its GM North America, GM International, and GM Financial segments, operating brands such as Chevrolet, GMC, Cadillac, and Buick alongside a captive lending arm. GM is a scale incumbent rather than a disruptor — it reclaimed U.S. market leadership in 2022 and held roughly 17.4% U.S. share in 2025 — but its identity is increasingly shaped by capital return and software/services ambitions layered on top of a cyclical, capital-intensive core. The current investor debate centers on whether GM's raised cash flow guidance, aggressive buyback program, and high-margin software growth can offset tariff and commodity cost headwinds, particularly the threatened doubling of Canadian tariffs that has dominated recent headlines. Bulls frame GM as a deep-value cash-return story trading near trough multiples, while bears point to a volatile earnings record — including a large Q4 2025 loss — and thin net margins that leave little cushion against trade policy shocks.

People also watch

Tesla

Tesla

TSLA

Analysis
Ford Motor Company

Ford Motor Company

F

Analysis
Rivian Automotive

Rivian Automotive

RIVN

Analysis
Lucid Motors

Lucid Motors

LCID

Analysis
Amazon

Amazon

AMZN

Analysis

GM 12-Month Price Forecast

Historical Price
Current Price $87.40
Average Target $87.40
High Target $100.51
Low Target $74.29

Wall Street consensus

Most Wall Street analysts maintain a constructive view on General Motors's 12-month outlook, with a consensus price target around $101.09 and implied upside of +15.7% versus the current price.

Average Target

$101.09

0 analysts

Implied Upside

+15.7%

vs. current price

Analyst Count

—

covering this stock

Price Range

$75 - $132

Analyst target range

Coverage is robust, with 23 analysts and a consensus recommendation of "buy" (mean rating of 1.625 on a 1-5 scale where lower is more bullish). The average target price of $101.22 implies roughly +33.3% upside from the current $75.92, a wide gap that reflects the disconnect between depressed trailing earnings and the $21.59 consensus EPS estimate for the forward period. The consensus clearly leans bullish, and the institutional ratings flow supports that: Jefferies upgraded from Hold to Buy on July 27, 2026, while UBS, Tigress Financial, RBC, JPMorgan, Goldman Sachs, Morgan Stanley, TD Cowen, and Barclays all maintained Buy/Overweight/Outperform ratings, with Wells Fargo the lone Underweight holdout. The target range runs from a low of $75.00 — essentially the current price, implying zero upside — to a high of $132.00, a spread of 76% of the low end that signals substantial disagreement about the earnings trajectory. The high target likely assumes successful tariff mitigation, delivery of the raised cash flow guidance, multiple expansion off trough levels, and continued software margin contribution; the low target of $75 prices in margin compression and tariff escalation, effectively assuming the current depressed valuation is fair. The wide spread, combined with the recent 9.37% one-month decline, suggests high uncertainty and that the market is currently trading closer to the bear case than the consensus view — a setup where delivery against guidance would need to be strong to close the gap to the $101 average.

Drowning in data?

Find the real signal!

Bulls vs Bears: GM Investment Factors

The bear case currently has stronger near-term evidence: margins have compressed sharply (7.61% gross in Q2 2026 versus 9.05% a year ago), revenue is growing under 2%, momentum is decisively negative with -17.70% YTD relative strength, and tariff headlines have already produced a -6.8% single-day gap. The bull case rests on valuation and cash return rather than current earnings power — a 5.13x forward PE, $16.50 billion TTM free cash flow, and a 33.3% gap to the $101.22 consensus target. The single most important tension is whether the $21.59 forward EPS estimate is achievable: if margins normalize toward prior-cycle levels the stock is deeply undervalued, but if tariffs and commodity costs keep gross margins near 7-8%, the forward multiple is an illusion and the $75 analyst low becomes the fair value.

Bullish

  • Forward PE of 5.1x prices a deep cyclical trough: GM trades at just 5.13x consensus forward EPS of $21.59 versus a meaningless 24.4x trailing multiple distorted by the Q4 2025 loss. The 0.40x price-to-sales and 1.22x price-to-book sit at or below the low end of GM's historical 1.0x-2.9x PS and 0.61x-1.42x PB bands, implying the market is discounting the recovery rather than paying for it.
  • Analyst consensus implies 33% upside: All 23 covering analysts average a $101.22 target, roughly +33.3% from the $75.92 price, with a 'buy' mean rating of 1.625. Jefferies upgraded to Buy in July 2026 and eight other firms (UBS, RBC, JPMorgan, Goldman, Morgan Stanley, TD Cowen, Barclays, Tigress) carry Buy/Overweight/Outperform, leaving Wells Fargo as the lone Underweight.
  • Free cash flow funds aggressive capital return: TTM free cash flow of $16.50 billion and $4.41 billion in Q2 2026 alone comfortably funded $2.0 billion of buybacks and $608 million of dividends in that quarter, with capex of $1.94 billion covered 3.27x by operating cash flow. Share count has already fallen from 1.115 billion in Q4 2024 to 919 million in Q2 2026, mechanically lifting EPS.
  • Raised cash flow guidance and software mix shift: Management has raised cash flow guidance and is layering high-margin software and services revenue ($1.55 billion in Q2 2026) on top of the core vehicle business ($41.58 billion). GM also holds roughly 17.4% U.S. market share in 2025, up 60 basis points, giving it scale to defend pricing.

Bearish

  • Margin collapse leaves almost no cushion: Q2 2026 gross margin fell to 7.61% from 9.05% a year earlier, net margin to 2.65%, and operating margin to roughly 1.6% (operating income of $1.46 billion on $48.03 billion revenue). Q4 2025 posted a negative 2.48% gross margin and a $3.31 billion loss, showing how quickly profitability can invert.
  • Revenue growth is barely positive: Q2 2026 revenue of $48.03 billion grew only 1.92% year-over-year, and Q1 2026 revenue of $43.62 billion actually declined from $44.02 billion a year earlier. With the core vehicle, parts and accessories segment at $41.58 billion driving essentially all of the trajectory, there is no organic acceleration to offset cost pressure.
  • Leverage and weak returns on capital: Debt-to-equity of 2.13 and total debt near 67% of capitalization sit alongside ROE of just 4.41% and ROA of 2.77%, inflated by an equity multiplier of roughly 4.56x. Trailing EPS of $0.036 means the 24.4x trailing PE is economically meaningless and the entire thesis rests on forward estimates being delivered.
  • Tariff policy is an unresolved binary risk: The threatened doubling of Canadian tariffs has repeatedly repriced the stock, including a single-session drop from $82.75 on October 19 to $77.09 on October 20 (-6.8%). A $132 high versus $75 low analyst target range (76% spread) quantifies how much disagreement exists about tariff mitigation and margin recovery.

GM Technical Analysis

GM is in a choppy, range-bound consolidation rather than a clean trend: the stock is up 13.57% over the past year but sits only 82.7% of the way through its 52-week range (low of $66.75, high of $91.85), with the current $75.92 price roughly $15.93 below the high and $9.17 above the low. That mid-to-lower positioning signals neither momentum leadership nor a falling knife — it reflects a market that has repeatedly repriced GM on tariff headlines, with the 52-week high set during the late-July/August surge to $90.30 and the subsequent fade leaving the stock in the lower half of its band. The 1-year gain of 13.57% is essentially in line with SPY's 13.13%, but the relative strength of just +0.44% over 12 months masks severe underperformance in shorter windows. Recent momentum has deteriorated sharply: the stock is down 9.37% over the past month versus SPY's -1.02% (relative strength -8.35%), down 8.13% over three months against SPY's +2.85% (relative strength -10.98%), and down 6.25% year-to-date versus SPY's +11.45% (relative strength -17.70%). The 1-month decline directly contradicts the positive 1-year trend, a bearish divergence that suggests the August highs near $90 were a failed breakout and that the stock is in a mean-reversion pullback; the sharp drop from $82.75 on October 19 to $77.09 on October 20 (-6.8% in a single session) points to a news-driven repricing rather than gradual drift. Key support sits at the $66.75 52-week low, with intermediate support around the $75-$76 area where the stock has repeatedly found buyers; resistance is the $91.85 high, with the $87-$90 zone acting as the prior breakdown shelf. A break below $75 would open the door to a retest of the 52-week low and confirm the downtrend, while reclaiming $87 would repair the technical damage. With a beta of 1.40, GM is roughly 40% more volatile than the market, and its -16.2% max drawdown underscores that position sizing must account for amplified moves — particularly with a short ratio of 2.68 indicating moderate but not extreme bearish positioning.

Beta

1.40

1.40x market volatility

Max Drawdown

-16.2%

Largest decline past year

52-Week Range

$67-$92

Price range past year

Annual Return

+27.3%

Cumulative gain past year

PeriodGM ReturnS&P 500
1m+13.5%-0.9%
3m-1.6%+1.2%
6m+15.3%+4.9%
1y+27.3%+11.2%
ytd+7.9%+10.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

GM Fundamental Analysis

Revenue is growing but only modestly: Q2 2026 revenue of $48.03 billion rose 1.92% year-over-year from $47.12 billion, continuing a pattern of low-single-digit top-line expansion (Q1 2026 was $43.62 billion versus $44.02 billion a year earlier, a slight decline). The mix is dominated by vehicle, parts, and accessories at $41.58 billion, with GM Financial contributing $4.26 billion, services and other $1.55 billion, and used vehicles $0.63 billion — meaning the core industrial business drives essentially all of the trajectory, and the modest growth implies a mature, share-defending posture rather than an accelerating story. The investment case therefore rests less on revenue growth and more on cash generation and capital return, consistent with management's raised cash flow guidance and buyback emphasis. Profitability is thin and volatile: Q2 2026 net income was $1.27 billion on a 2.65% net margin and 7.61% gross margin, a sharp step down from Q1 2026's $2.63 billion net income, 6.02% net margin, and 11.45% gross margin. The trailing picture is distorted by a Q4 2025 loss of $3.31 billion (EPS -$3.60) driven by a negative 2.48% gross margin, which dragged trailing EPS to just $0.036 and trailing net margin to 1.46%; the Q2 2026 gross margin of 7.61% is also well below the 9.05% recorded in Q2 2025, indicating margin compression from tariffs and commodity costs. At roughly 1.6% operating margin, GM is running far below what is typical for scaled automakers in healthy cycles, leaving little buffer. The balance sheet carries meaningful leverage — debt-to-equity of 2.13 and total debt-to-capitalization near 67% — but liquidity is adequate with a current ratio of 1.17 and $23.58 billion in cash at the end of Q2 2026. Free cash flow is the bright spot: $16.50 billion TTM and $4.41 billion in Q2 2026 alone, funding $2.0 billion of buybacks and $608 million of dividends in the quarter, with capex of $1.94 billion covered 3.27x by operating cash flow. ROE of 4.41% and ROA of 2.77% are weak in absolute terms, reflecting the equity multiplier of roughly 4.56x, but the cash generation means GM can fund growth and returns internally without relying on external financing — the key support for the value thesis.

Quarterly Revenue

$48.0B

2026-06

Revenue YoY Growth

+1.9%

YoY Comparison

Gross Margin

7.6%

Latest Quarter

Free Cash Flow

$16.5B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Vehicle, parts, and accessories
Used vehicles
Services and other
GM Financial

Open an Account, get $2 TSLA now!

Valuation Analysis: Is GM Overvalued?

Because trailing net income is positive but negligible (EPS of $0.036), the trailing PE of 24.42x is economically meaningless and distorted by the Q4 2025 loss; the more informative metric is the forward PE of 5.13x, which reflects consensus EPS estimates of $21.59 and signals that the market expects a sharp earnings recovery. The enormous gap between the 24.4x trailing and 5.1x forward multiple implies the market is pricing a normalization of profitability rather than extrapolating the depressed trailing base — a classic cyclical-trough setup. On EV/EBITDA of 9.99x and EV/sales of 0.91x, GM looks inexpensive for a company with $195.5 billion in estimated revenue. Peer comparison is constrained because the provided valuation dataset contains no explicit industry-average multiples, so a direct spread cannot be quantified; however, GM's 0.40x price-to-sales and 1.22x price-to-book are consistent with a deep-value profile, and its 5.1x forward PE sits at the low end of what large-cap industrials typically command. The premium/discount question is therefore best framed against GM's own history: the stock has historically traded in a roughly 3.5x-14x PE band, and the current forward multiple of 5.1x implies the market is applying a severe discount for cyclicality, tariff risk, and earnings volatility rather than paying for the software and cash-return narrative. Historically, GM's PS ratio has ranged from about 1.0x to 2.9x over the past several years, and the current 0.40x PS (on the provided valuation data) is at or below the bottom of that band, while the 1.22x PB is near the low end of its 0.61x-1.42x historical range. That positioning suggests either a genuine value opportunity or a market that doubts the durability of the earnings recovery embedded in the forward estimates — the resolution likely hinges on tariff outcomes and whether the raised cash flow guidance is delivered.

PE

24.4x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 3x~12x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

10.0x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are acute because profitability is thin and volatile. Q2 2026 net income of $1.27 billion represented a 2.65% net margin and 7.61% gross margin, down from 9.05% gross a year earlier, while Q4 2025 produced a $3.31 billion loss on a negative 2.48% gross margin. Trailing EPS of just $0.036 means a modest earnings miss would erase the entire trailing profit base, and debt-to-equity of 2.13 with roughly 67% debt-to-capitalization leaves limited balance-sheet flexibility, even though $23.58 billion of cash and a 1.17 current ratio provide adequate near-term liquidity. Revenue concentration in the core vehicle, parts and accessories segment ($41.58 billion of $48.03 billion) means there is no diversified earnings stream to absorb a North American downturn.

Market and competitive risks center on valuation compression and trade policy. GM's 5.13x forward PE is already a discount, but that discount can persist or widen if the market loses confidence in the $21.59 consensus EPS; the 76% spread between the $75 low and $132 high analyst targets shows how unstable estimates are. The threatened doubling of Canadian tariffs is the dominant external threat and has already caused a -6.8% single-session repricing on October 20, 2026, while commodity cost headwinds are explicitly cited in recent coverage. With a beta of 1.40, GM amplifies market moves by roughly 40%, and its -17.70% YTD relative strength versus SPY means any sector rotation away from cyclicals would hit it harder than the index.

The worst-case scenario is a tariff escalation combined with a U.S. volume slowdown that pushes gross margins back toward the negative territory seen in Q4 2025, forcing consensus EPS of $21.59 to be cut sharply and triggering analyst downgrades from the current 1.625 mean rating. In that chain, the stock would retest its 52-week low of $66.75, which is roughly -12.1% from the current $75.92, and a break below the $75-$76 support shelf would confirm the downtrend. The analyst low target of $75.00 implies essentially zero downside from here, but the -16.2% max drawdown and the 1.40 beta show that a genuine adverse scenario could overshoot the 52-week low; investors should size positions for a realistic -12% to -20% drawdown rather than the consensus-implied flat outcome.